NCT01252290View on ClinicalTrials.gov

Breast Cancer Risk Biomarkers in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Breast Cancer

Interventions

DRUG

Lovaza™

4 capsules daily for 6 months

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Carol Fabian, MD

OTHER